Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters. ONL Therapeutics, Inc. announced...
ONL Therapeutics’ $65 Million Series D Financing Round
SK Biopharmaceuticals’ License Agreement with Full-Life Technologies
Ropes & Gray represented SK Biopharmaceuticals on the transaction. SK Biopharmaceuticals announced it has entered into an global licensing agreement with radiotherapy company Full-Life Technologies (“Full-Life”)...
Green Mobility Holding’s Acquisition of A-DIGITAL one GmbH
Sidley Austin advised Green Mobility Holding on the transaction. Rivean Capital’s portfolio company, Green Mobility Holding, announced its acquisition of the digital agency A-DIGITAL one GmbH....
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
Glean’s $260 Million Series E Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Altimeter, DST Global, Craft Ventures and Coatue, as investors in the transaction. Glean, an AI enterprise search startup,...
Finkargo’s $20 Million Equity Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Finkargo in the deal. Finkargo, a Latin American-based fintech, announced raising $20 million in equity financing led by...
Warburg Pincus’ Inaugural $4 Billion Capital Solutions Fund
Kirkland & Ellis represented Warburg Pincus in the transaction. Warburg Pincus, a leading global growth investor, announced the formation of its inaugural capital solutions fund, Warburg...
Aztec Group’s Partnership with Warburg Pincus
Latham & Watkins, PriestlySoundy, and Carey Olsen advised Aztec Group on the transaction, while Kirkland & Ellis advised Warburg Pincus Aztec Group (Aztec), a leading international...
Neo Medical SA’s Series B and $68 Million Equity Investment
Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
Bicara Therapeutics’ $315 Million IPO
Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...
Strider’s $55 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Strider Technologies, Inc. on the transaction. Strider Technologies, Inc., a leading provider of strategic intelligence, announced that it has closed...
Royalty Pharma’s $150 Million Royalty Funding Agreement with Ascendis Pharma
Fenwick & West and Goodwin Procter represented Royalty Pharma plc in the transaction, and Latham & Watkins and Mazanti-Andersen represented Ascendis Pharma A/S. Ascendis Pharma A/S...